SINGAPORE – Global biopharmaceutical company AstraZeneca intends to build a US$1.5 billion (S$2 billion) manufacturing facility in Singapore, the company said on May 20. It aims to begin the designing and construction of the facility by the end of 2024 and targets it to be operationally ready from 2029. The company’s new facility in Singapore
Disclaimer : Mymoneytimes implements extreme caution and care in collecting data before publication. Mymoneytimes does not liable for the adequacy, accuracy or completeness of any given information. Hence we are not liable for any kind of direct or indirect loss caused by the use of such information.